查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404689

脑血栓切除装置市场规模、份额、趋势分析报告：按产品、最终用途、按地区、细分市场预测，2024-2030 年

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/ Suction Devices), By End-use (Hospitals, Emergency Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

脑血栓切除装置市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球脑血栓切除设备市场规模将达11亿美元，2024年至2030年复合年增长率为6.87%。

市场成长是由多种因素推动的，例如中风盛行率增加、不健康生活方式的增加、微创手术需求的增加以及市场参与企业采取的各种策略性倡议。Masu。与传统的开颅手术相比，这些设备具有简化伤口缝合和加速创伤治疗的优点。例如，易于进入颅内空间、微创性以及与脑血栓切除装置相关的先进设计和功能简化了困难的手术。

此外，所有年龄层的人对更美观、更自然的外观越来越感兴趣，以及微创手术期间更少的失血也是市场成长的关键驱动因素。此类手术预计将比侵入性手术更有助于减少创伤并促进更快的康復。如上所述，由于脑血栓切除装置可减少失血并加快恢復速度，因此对微创手术的需求预计将会增加。此外，技术先进产品的推出和快速的产品核可流程预计将在预测期内推动市场成长。各种其他技术已被用于开发用于治疗 AIS 和相关病症的脑血栓切除装置。例如，2023年6月，Penumbra推出了闪电Bolt7动脉血栓切除系统。该设备有助于区分血块和血流。

脑血栓切除设备市场报告亮点：

  • 从产品来看，由于急性缺血性脑中风上升以及主要市场参与企业增加产品推出，血栓切除设备在 2023 年占据市场主导地位，份额为 58.24%。
  • 按最终用途划分，由于医院医疗设施的改善和先进设备的配备，医院细分市场在2023年占据市场主导地位，份额为71.25%。
  • 由于急性缺血性脑中风患者的增加，欧洲在 2023 年以 32.74% 的最大销售份额引领市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章脑血栓切除装置市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 产业价值链分析
    • 赎回框架
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 脑血栓切除装置市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略联盟分析
    • 打入市场策略

第四章脑血栓切除装置市场：产品估算与趋势分析

  • 定义和范围
  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 按产品分類的脑血栓切除设备市场前景
  • 2018年至2030年市场规模、预测与趋势分析

第五章脑血栓切除装置市场：最终用途估计与趋势分析

  • 定义和范围
  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 依最终用途分類的脑血栓切除装置市场前景
  • 2018年至2030年市场规模、预测与趋势分析

第六章脑血栓切除装置市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2023年区域市场占有率和主要企业
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2018-2030年市场应用、预测及趋势分析
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • 创新者
  • 供应商形势
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Medtronic
    • Acandis GmbH
    • Phenox GmbH
    • Stryker
    • Penumbra, Inc.
    • Vesalio
Product Code: GVR-2-68038-941-8

Neurothrombectomy Devices Market Growth & Trends:

The global neurothrombectomy devices market size is expected to reach USD 1.10 billion by 2030, growing at 6.87% CAGR from 2024 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights:

  • Based on products, clot retrievers segment dominated the market in 2023, with a share of 58.24% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players
  • Based on end-use, hospital segment dominated the market in 2023 with a share of 71.25% due to improving health care facilities and the availability of advanced equipment in the hospitals
  • Europe led the market with the maximum revenue share of 32.74% in 2023, owing to the increasing number of patients suffering from acute ischemic stroke in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Neurothrombectomy Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of acute ischemic strokes
      • 3.4.1.2. Introduction of technologically advanced products
      • 3.4.1.3. Rising Adoption of unhealthy lifestyle
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Stringent and complex regulatory framework
      • 3.4.2.2. Risks associated with the neurothrombectomy devices
  • 3.5. Neurothrombectomy Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. The threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Clot Retrievers
    • 4.1.2. Aspiration/Suction Devices
    • 4.1.3. Vascular Snares
  • 4.2. Type Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Neurothrombectomy Devices Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Clot Retrievers
      • 4.5.1.1. Clot Retrievers market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Aspiration/Suction Devices
      • 4.5.2.1. Aspiration/Suction Devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3 Vascular Snares
      • 4.5.3.1 Vascular Snares market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Neurothrombectomy Devices Market: End-use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Hospital
    • 5.1.2. Emergency Clinics
    • 5.1.3. Ambulatory Surgical Centers
  • 5.2. End-use Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Neurothrombectomy Devices Market by End-use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Hospital
      • 5.5.1.1. Hospital market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Emergency Clinics
      • 5.5.2.1. Emergency Clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Ambulatory Surgical Centers
      • 5.5.3.1. Ambulatory Surgical Centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2023
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
  • 6.6. North America
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. U.S.
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 6.6.3. Canada
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.7. Europe
    • 6.7.1. UK
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 6.7.2. Germany
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 6.7.3. France
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 6.7.4. Italy
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 6.7.5. Spain
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 6.7.6. Denmark
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 6.7.7. Sweden
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Competitive scenario
      • 6.7.7.3. Regulatory framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 6.7.8. Norway
      • 6.7.8.1. Key country dynamics
      • 6.7.8.2. Competitive scenario
      • 6.7.8.3. Regulatory framework
      • 6.7.8.4. Reimbursement scenario
      • 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 6.8. Asia Pacific
    • 6.8.1. Japan
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 6.8.2. India
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 6.8.3. China
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 6.8.4. South Korea
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Competitive scenario
      • 6.8.4.3. Regulatory framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 6.8.5. Australia
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Competitive scenario
      • 6.8.5.3. Regulatory framework
      • 6.8.5.4. Reimbursement scenario
      • 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 6.8.6. Thailand
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Competitive scenario
      • 6.8.6.3. Regulatory framework
      • 6.8.6.4. Reimbursement scenario
      • 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 6.9. Latin America
    • 6.9.1. Brazil
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 6.9.2. Mexico
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 6.9.3. Argentina
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 6.10. MEA
    • 6.10.1. South Africa
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Competitive scenario
      • 6.10.1.3. Regulatory framework
      • 6.10.1.4. Reimbursement scenario
      • 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 6.10.2. Saudi Arabia
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Competitive scenario
      • 6.10.2.3. Regulatory framework
      • 6.10.2.4. Reimbursement scenario
      • 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 6.10.3. UAE
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Competitive scenario
      • 6.10.3.3. Regulatory framework
      • 6.10.3.4. Reimbursement scenario
      • 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 6.10.4. Kuwait
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Competitive scenario
      • 6.10.4.3. Regulatory framework
      • 6.10.4.4. Reimbursement scenario
      • 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Medtronic
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Acandis GmbH
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Phenox GmbH
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Stryker
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Penumbra, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Vesalio
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global neurothrombectomy devices market, by region 2018 - 2030 (USD Million)
  • Table 4 Global neurothrombectomy devices market, by product 2018 - 2030 (USD Million)
  • Table 5 Global neurothrombectomy devices market, by end-use 2018 - 2030 (USD Million)
  • Table 6 North America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Europe neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 UK neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Germany neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 France neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 France neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Italy neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 Italy neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Spain neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Spain neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Sweden neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Sweden neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Norway neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Norway neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Denmark neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 31 Denmark neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 China neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 36 China neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 India neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 38 India neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 40 South Korea neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 42 Australia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Thailand neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Thailand neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Mexico neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Neurothrombectomy devices market: Market snapshot
  • Fig. 9 Neurothrombectomy devices market: Market segmentation
  • Fig. 10 Neurothrombectomy devices market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Neurothrombectomy devices market driver impact
  • Fig. 14 Neurothrombectomy devices market restraint impact
  • Fig. 15 Neurothrombectomy devices market Porter's five forces analysis
  • Fig. 16 Neurothrombectomy devices market PESTEL analysis
  • Fig. 17 Neurothrombectomy devices market segment dashboard
  • Fig. 18 Neurothrombectomy devices market: Product movement Analysis
  • Fig. 19 Clot retrievers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Aspiration/ suction devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Vascular snares market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Neurothrombectomy devices market: End-use movement Analysis
  • Fig. 23 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Emergency clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Ambulatory surgical centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global neurothrombectomy devices market: Regional movement analysis
  • Fig. 27 Global neurothrombectomy devices market: Regional outlook and key takeaways
  • Fig. 28 Global market share, by region
  • Fig. 29 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)